Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 67,108Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Pfizer Inc

02 9Pierre Fabre

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2018-06-27

Application Number : 210496

Regulatory Info : DISCN

Registration Country : USA

blank

02

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE;ORAL

Dosage Strength : 75MG

Packaging :

Approval Date : 2018-06-27

Application Number : 210496

Regulatory Info : RX

Registration Country : USA

blank

03

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE

Dosage Strength : 75MG

Packaging :

Approval Date :

Application Number : 2513099

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Kaps

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Kaps

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Kaps

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

11

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

12

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank